EUVIMEDObjevte EUVIMED
Crossref

Leucine‐Rich Alpha‐2 Glycoprotein Is Associated With Transmural Inflammation Assessed by Intestinal Ultrasound in Patients With Crohn's Disease

Moeko Komatsu iD, Shintaro Sagami iD, Aya Hojo iD, Ryo Karashima iD, Masa Maeda iD, Yoko Yamana iD, Kanade Serizawa, Satoko Umeda, Kunio Asonuma iD, Masaru Nakano iD, Toshifumi Hibi iD, Takahisa Matsuda iD and 1 more

Alimentary Pharmacology & Therapeutics · 2025-02 · 61 (4) · 658-666

DOI: 10.1111/apt.18430 ↗

At a glance

Journal article in Alimentary Pharmacology & Therapeutics, published online on 2024-12-06. Written by Moeko Komatsu and 12 co-authors. Institution: Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital, Minato-ku, Tokyo, Japan. Major MEDLINE topics: Crohn Disease, Glycoproteins, Inflammation, Intestines. Cited 9 times so far (Crossref); 35 references. Funded by: Kitasato University Kitasato Institute Hospital.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Intestinal ultrasound (IUS) is a non‐invasive tool for evaluating transmural inflammation in Crohn's disease (CD). However, its utility is constrained by operator dependency and limited accessibility.

Aims

To explore the feasibility of serum biomarkers—specifically leucine‐rich alpha‐2 glycoprotein (LRG)—as an alternative to IUS for assessing transmural inflammation.

Methods

This retrospective, single‐centre study included patients with CD who underwent IUS and measurements of LRG and C‐reactive protein (CRP). We assessed correlations between biomarkers and five IUS scores (Limberg score, Bowel Ultrasound Score (BUSS), International Bowel Ultrasound Segmental Activity Score (IBUS‐SAS), Simple Ultrasound Score (Simple‐US) and Simple Ultrasound Score for Crohn's Disease (SUS‐CD)) using receiver operator characteristic curve analysis and Spearman's rank correlation coefficient. We conducted subgroup analyses for patients in clinical remission.

Results

We analysed 213 IUS examinations performed on 97 patients; 170 (80%) IUS were during clinical remission. The area under the curve for LRG for each IUS score (0.76, 0.80, 0.77, 0.75 and 0.69, respectively) was superior to that of CRP and was statistically significant, particularly for LS, BUSS, IBUS‐SAS and Simple‐US ( p < 0.001, p = 0.018, p < 0.001 and p < 0.001, respectively). Predictive values remained consistent among patients in remission. LRG demonstrated excellent correlation with IUS scores in both the overall patient population and those in remission.

Conclusion

LRG showed a robust correlation with IUS scores, suggesting its potential as a novel indicator for targeting transmural healing in patients with CD.

Subjects

MeSH terms (MEDLINE)

Crohn DiseaseGlycoproteinsInflammationIntestinesHumansMaleFemaleAdultRetrospective StudiesBiomarkersUltrasonographyMiddle AgedC-Reactive ProteinYoung AdultSeverity of Illness IndexROC CurveFeasibility StudiesAdolescent

Author keywords

Crohn's diseaseintestinal ultrasoundleucine‐rich alpha‐2 glycoprotein

Substances

BiomarkersC-Reactive ProteinGlycoproteinsLRG1 protein, human

Authors and institutions

  • Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital, Minato-ku, Tokyo, Japan.
  • Department of Gastroenterology, Kitasato University Kitasato Institute Hospital, Minato-ku, Tokyo, Japan.
  • Division of Gastroenterology and Hepatology, Toho University Omori Medical Center, Ota-ku, Tokyo, Japan.
  • Department of Gastroenterology, Kitasato University School of Medicine, Kanagawa, Japan.

ORCID profiles: Moeko Komatsu, Shintaro Sagami, Aya Hojo, Ryo Karashima, Masa Maeda, Yoko Yamana, Kunio Asonuma, Masaru Nakano, Toshifumi Hibi, Takahisa Matsuda, Taku Kobayashi

Funding

  • Kitasato University Kitasato Institute Hospital

Cite

APA

Komatsu, M., Sagami, S., Hojo, A., Karashima, R., Maeda, M., Yamana, Y., Serizawa, K., Umeda, S., Asonuma, K., Nakano, M., Hibi, T., Matsuda, T., & Kobayashi, T. (2025). Leucine‐Rich Alpha‐2 Glycoprotein Is Associated With Transmural Inflammation Assessed by Intestinal Ultrasound in Patients With Crohn's Disease. Alimentary Pharmacology & Therapeutics, 61(4), 658-666. https://doi.org/10.1111/apt.18430

Vancouver

Komatsu M, Sagami S, Hojo A, Karashima R, Maeda M, Yamana Y, et al. Leucine‐Rich Alpha‐2 Glycoprotein Is Associated With Transmural Inflammation Assessed by Intestinal Ultrasound in Patients With Crohn's Disease. Alimentary Pharmacology & Therapeutics. 2025;61(4):658-666. doi:10.1111/apt.18430

BibTeX
@article{Komatsu2025,
  author = {Komatsu, Moeko and Sagami, Shintaro and Hojo, Aya and Karashima, Ryo and Maeda, Masa and Yamana, Yoko and Serizawa, Kanade and Umeda, Satoko and Asonuma, Kunio and Nakano, Masaru and Hibi, Toshifumi and Matsuda, Takahisa and Kobayashi, Taku},
  title = {Leucine‐Rich Alpha‐2 Glycoprotein Is Associated With Transmural Inflammation Assessed by Intestinal Ultrasound in Patients With Crohn's Disease},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2025},
  volume = {61},
  number = {4},
  pages = {658--666},
  doi = {10.1111/apt.18430}
}
Start for free →